29 November 2021

Matsoukas, John ORCID: 0000-0001-5554-2964, Ligielli, Irene, Chasapis, Christos T, Kelaidonis, Konstantinos, Apostolopoulos, Vasso ORCID: 0000-0001-6788-2771 and Mavromoustakos, Thomas (2021) Novel Approaches in the Immunotherapy of Multiple Sclerosis: Cyclization of Myelin Epitope Peptides and Conjugation with Mannan. Brain Sciences, 11 (12). ISSN 2076-3425

4 May 2022

Ridgway, Harry, Moore, Graham J, Mavromoustakos, Thomas, Tsiodras, Sotirios, Ligielli, Irene, Kelaidonis, Konstantinos, Chasapis, Christos T, Gadanec, Laura Kate ORCID: 0000-0002-4801-8061, Zulli, Anthony ORCID: 0000-0002-2660-078X, Apostolopoulos, Vasso ORCID: 0000-0001-6788-2771, Petty, Russell, Karakasiliotis, Ioannis, Gorgoulis, Vassilis G and Matsoukas, John ORCID: 0000-0001-5554-2964 (2022) Discovery of a new generation of angiotensin receptor blocking drugs: receptor mechanisms and in silico binding to enzymes relevant to SARS-CoV-2. Computational and Structural Biotechnology Journal, 20. pp. 2091-2111. ISSN 2001-0370

11 May 2022

Ridgway, Harry, Chasapis, Christos T ORCID: 0000-0002-8728-6245, Kelaidonis, Konstantinos, Ligielli, Irene, Moore, Graham J, Gadanec, Laura Kate ORCID: 0000-0002-4801-8061, Zulli, Anthony ORCID: 0000-0002-2660-078X, Apostolopoulos, Vasso ORCID: 0000-0001-6788-2771, Mavromoustakos, Thomas ORCID: 0000-0001-5309-992X and Matsoukas, John ORCID: 0000-0001-5554-2964 (2022) Understanding the driving forces that trigger mutations in SARS‐CoV‐2: mutational energetics and the role of arginine blockers in COVID‐19 therapy. Viruses, 14 (5). ISSN 1999-4915

18 July 2022

Matsoukas, John ORCID: 0000-0001-5554-2964, Gadanec, Laura Kate ORCID: 0000-0002-4801-8061, Zulli, Anthony ORCID: 0000-0002-2660-078X, Apostolopoulos, Vasso ORCID: 0000-0001-6788-2771, Kelaidonis, Konstantinos, Ligielli, Irene, Moschovou, Kalliopi, Georgiou, Nikitas, Plotas, Panagiotis, Chasapis, Christos T ORCID: 0000-0002-8728-6245, Moore, Graham, Ridgway, Harry and Mavromoustakos, Thomas ORCID: 0000-0001-5309-992X (2022) Diminazene aceturate reduces angiotensin II constriction and interacts with the spike protein of severe acute respiratory syndrome Coronavirus 2. Biomedicines, 10 (7). ISSN 2227-9059